CORGENIX MEDICAL CORP/CO (CONX) financial statements (2020 and earlier)

Company profile

Business Address 11575 MAIN STREET
BROOMFIELD, CO 80020
State of Incorp. CO
Fiscal Year End June 30
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2014
TTM
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 2,4411,957
Cash and cash equivalents 2,4411,957
Receivables 1,7272,468
Inventory, net of allowances, customer advances and progress billings 1,7822,033
Inventory 1,7822,033
Prepaid expense 87
Prepaid expense and other current assets18
Other undisclosed current assets 255(968)
Total current assets: 6,2925,507
Noncurrent Assets
Property, plant and equipment 1,127895
Long-term investments and receivables 1212
Due from related parties 1212
Intangible assets, net (including goodwill) 227260
Intangible assets, net (excluding goodwill) 227260
Other noncurrent assets 131
Prepaid expense and other noncurrent assets58
Total noncurrent assets: 1,4971,225
TOTAL ASSETS: 7,7896,733
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1,038846
Accounts payable 556477
Accrued liabilities 164149
Employee-related liabilities 318220
Debt 84108
Total current liabilities: 1,122954
Noncurrent Liabilities
Long-term debt and lease obligation 16917
Capital lease obligations 16917
Other undisclosed noncurrent liabilities 283329
Total noncurrent liabilities: 452346
Total liabilities: 1,5741,300
Stockholders' equity
Stockholders' equity attributable to parent, including: 6,2155,421
Additional paid in capital 22,12021,700
Accumulated deficit (15,958)(16,329)
Other undisclosed stockholders' equity attributable to parent 5350
Other undisclosed stockholders' equity  12
Total stockholders' equity: 6,2155,433
TOTAL LIABILITIES AND EQUITY: 7,7896,733

Income statement (P&L) ($ in thousands)

12/31/2014
TTM
6/30/2014
6/30/2013
Revenues
(Revenue, Net)
 11,01210,188
Cost of revenue
(Cost of Goods and Services Sold)
 (5,721)(5,624)
Gross profit: 5,2914,564
Operating expenses (4,891)(4,267)
Operating income: 400296
Nonoperating expense (14)(18)
Interest and debt expense (15)(21)
Income from continuing operations before equity method investments, income taxes: 371258
Other undisclosed income from continuing operations before income taxes 15 
Income from continuing operations before income taxes: 385258
Income tax expense (14) 
Net income: 371258
Other undisclosed net income attributable to parent  21
Net income attributable to parent: 371279
Preferred stock dividends and other adjustments  (3)
Net income available to common stockholders, diluted: 371275

Comprehensive Income ($ in thousands)

12/31/2014
TTM
6/30/2014
6/30/2013
Net income: 371258
Comprehensive income, net of tax, attributable to parent: 371258

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: